Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
Need
A G
AG
Division of Clinical Chemistry, Institute of Medical and Veterinary Science, Adelaide, South Australia.
Nordin
B E
BE
Chatterton
B E
BE
D045930:Anabolic Agents / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects; D004311:Double-Blind Method; D005542:Forearm; D006801:Humans; D009277:Nandrolone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077603:Nandrolone Decanoate; D010024:Osteoporosis / Q000188:drug therapy* / Q000378:metabolism; D014831:Voice / Q000187:drug effects
D045930:Anabolic Agents; D009277:Nandrolone; D000077603:Nandrolone Decanoate